NTAP
65
-3
XOM
50
-6
HBAN
50
-4
SRCL
34
-2
HD
28
-3
MMM
37
5
TGNA
45
-3
GPS
49
-3
K
39
-5
MCHP
58
-5
APA
45
-5
GIS
60
-3
MS
66
-3
KLAC
63
-5
HPE
16
-5
ROK
39
-5
MLM
67
-9
NEE
52
-3
UNP
48
-5
LYB
37
-21
NTAP
65
-3
XOM
50
-6
HBAN
50
-4
SRCL
34
-2
HD
28
-3
MMM
37
5
TGNA
45
-3
GPS
49
-3
K
39
-5
MCHP
58
-5
APA
45
-5
GIS
60
-3
MS
66
-3
KLAC
63
-5
HPE
16
-5
ROK
39
-5
MLM
67
-9
NEE
52
-3
UNP
48
-5
LYB
37
-21
Financhill
Back

Insulet Quote, Financials, Valuation and Earnings

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Buy
51

PODD
Insulet

Last Price:
171.85
Seasonality Move:
5.64%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Insulet Price Quote

$171.85
-0.02 (-0.01%)
(Updated: May 1, 2024 at 10:05 AM ET)

Insulet Key Stats

Buy
51
Insulet (PODD) is a Buy
Day range:
$168.24 - $174.02
52-week range:
$125.82 - $335.91
Dividend yield:
0%
P/E ratio:
58.46
P/S ratio:
7.55
P/B ratio:
16.4%
Volume:
609.6K
Avg. volume:
723.9K
1-year change:
-45.96%
Market cap:
$12B
Revenue:
$1.7B
EPS:
$2.91

How Much Does Insulet Make?

  • How Much Are Insulet's Sales Annually?
    PODD Revenues are $1.7B
  • How Much Profit Does Insulet's Make A Year?
    PODD net income is $206.3M

Is Insulet Growing As A Company?

  • What Is Insulet's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.38%
  • What Is Insulet's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 5%

Insulet Stock Price Performance

  • Did Insulet Stock Go Up Last Month?
    Insulet share price went up by 0.27% last month
  • Did PODD's Share Price Rise Over The Last Year?
    PODD share price fell by -45.96% over the past 1 year

What Is Insulet 52-Week High & Low?

  • What Is Insulet’s 52-Week High Share Price?
    Insulet has traded as high as $335.91 over the past 52 weeks
  • What Is Insulet’s 52-Week Low Share Price?
    Insulet has traded as low as $125.82 over the past 52 weeks

Insulet Price To Free Cash Flow

  • Is Insulet Stock Overvalued?
    Insulet is trading at a price to free cash flow ratio of 350.88
  • Is Insulet Stock Undervalued?
    Insulet EV to Free Cash Flow ratio is 348.76
  • What Is Insulet’s Price Earnings Growth Ratio?
    PODD PEG ratio is 0.01
  • Is Insulet Trading At A Premium To Earnings?
    Insulet EV to EBIT ratio is 51.23

Is It Risky To Buy Insulet?

  • How Much Debt Does Insulet Have?
    Total long term debt quarterly is $1.4B
  • How Much Cash Does Insulet Have?
    Cash and short term investments quarterly total is $704.2M
  • What Is Insulet’s Book Value Per Share?
    Book value per share is 10.48

Is Insulet Cash Flow Positive?

  • What Is PODD Cash Flow From Operations?
    Cash flow from operations (TTM) is $145.7M
  • What Is Insulet’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$13.6M
  • What Is Insulet’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$119.4M

Insulet Return On Invested Capital

  • Is Management Doing A Good Job?
    PODD return on invested capital is 10.41%
  • What Is Insulet Return On Assets?
    ROA measures how assets are converting to revenues and is 8.61%
  • What Is PODD Return On Equity?
    ROE is a measure of profitability and is 35.9%

Insulet Earnings Date & Stock Price

  • What Is Insulet's Stock Price Today?
    A single share of PODD can be purchased today for 171.87
  • What Is Insulet’s Stock Symbol?
    Insulet trades on the nasdaq under the ticker symbol: PODD
  • When Is Insulet’s Next Earnings Date?
    The next quarterly earnings date for Insulet is scheduled on May 9, 2024
  • When Is PODD's next ex-dividend date?
    Insulet's next ex-dividend date is May 1, 2024
  • How To Buy Insulet Stock?
    You can buy Insulet shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Insulet Competitors

  • Who Are Insulet's Competitors?
    Below is a list of companies who compete with Insulet or are related in some way:
    • Abbott Laboratories (ABT)
    • Becton Dickinson & Co (BDX)
    • Haemonetics Corp (HAE)
    • Stryker Corp (SYK)
    • Tandem Diabetes Care Inc (TNDM)

Insulet Dividend Yield

Data Unavailable

Insulet Analyst Estimates

YoY Growth Past Surprise
EPS: 500% 111.44%
Revenue: 37.9% 10.57%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 236.27
Upside from Last Price: 37.47%

Major Shareholders

  • How many PODD shares are owned by institutional investors?
    131.8M PODD shares are owned by institutional investors
  • How many PODD shares are owned by insiders?
    2.1M PODD shares are owned by insiders